Strontium–Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment
Wenxiu Yuan, Jiaqi Liu, Zhenzhen Zhang, Chengxinyue Ye, Xueman Zhou, Yating Yi, Yange Wu, Yijun Li, Qinlanhui Zhang, Xin Xiong, Hengyi Xiao, Jin Liu, Jun Wang
International Journal of Oral Science ›› 2025, Vol. 17 ›› Issue (1) : 0.
Strontium–Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment
The ambiguity of etiology makes temporomandibular joint osteoarthritis (TMJOA) “difficult-to-treat”. Emerging evidence underscores the therapeutic promise of exosomes in osteoarthritis management. Nonetheless, challenges such as low yields and insignificant efficacy of current exosome therapies necessitate significant advances. Addressing lower strontium (Sr) levels in arthritic synovial microenvironment, we studied the effect of Sr element on exosomes and miRNA selectively loading in synovial mesenchymal stem cells (SMSCs). Here, we developed an optimized system that boosts the yield of SMSC-derived exosomes (SMSC-EXOs) and improves their miRNA profiles with an elevated proportion of beneficial miRNAs, while reducing harmful ones by pretreating SMSCs with Sr. Compared to untreated SMSC-EXOs, Sr-pretreated SMSC-derived exosomes (Sr-SMSC-EXOs) demonstrated superior therapeutic efficacy by mitigating chondrocyte ferroptosis and reducing osteoclast-mediated joint pain in TMJOA. Our results illustrate Alix’s crucial role in Sr-triggered miRNA loading, identifying miR-143-3p as a key anti-TMJOA exosomal component. Interestingly, this system is specifically oriented towards synovium-derived stem cells. The insight into trace element-driven, site-specific miRNA selectively loading in SMSC-EXOs proposes a promising therapeutic enhancement strategy for TMJOA.
[1.] |
|
[2.] |
|
[3.] |
|
[4.] |
|
[5.] |
You, D. G. et al. Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci. Adv. 7 https://doi.org/10.1126/sciadv.abe0083 (2021).
|
[6.] |
|
[7.] |
|
[8.] |
|
[9.] |
|
[10.] |
|
[11.] |
|
[12.] |
|
[13.] |
|
[14.] |
|
[15.] |
|
[16.] |
|
[17.] |
Qin, H. et al. Silencing miR-146a-5p protects against injury-induced osteoarthritis in mice. Biomolecules 13 https://doi.org/10.3390/biom13010123 (2023).
|
[18.] |
|
[19.] |
|
[20.] |
|
[21.] |
Song, J. E. et al. Role of synovial exosomes in osteoclast differentiation in inflammatory arthritis. Cells 10 https://doi.org/10.3390/cells10010120 (2021).
|
[22.] |
|
[23.] |
|
[24.] |
|
[25.] |
|
[26.] |
|
[27.] |
|
[28.] |
Tarale, P. et al. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson’s disease. Toxicol. In Vitro 46 https://doi.org/10.1016/j.tiv.2017.10.003 (2018).
|
[29.] |
|
[30.] |
|
[31.] |
|
[32.] |
|
[33.] |
|
[34.] |
|
[35.] |
|
[36.] |
|
[37.] |
|
[38.] |
|
[39.] |
|
[40.] |
|
[41.] |
|
[42.] |
|
[43.] |
|
[44.] |
|
[45.] |
|
[46.] |
|
[47.] |
|
[48.] |
|
[49.] |
|
[50.] |
|
[51.] |
|
[52.] |
|
[53.] |
|
[54.] |
|
[55.] |
|
[56.] |
|
[57.] |
|
[58.] |
|
[59.] |
|
[60.] |
|
[61.] |
|
[62.] |
Huang, Z. et al. MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway. Biosci. Rep. 39 https://doi.org/10.1042/BSR20182192 (2019).
|
[63.] |
|
[64.] |
|
[65.] |
Liu, X.-M., Ma, L. & Schekman, R. Selective sorting of microRNAs into exosomes by phase-separated YBX1 condensates. Elife 10 https://doi.org/10.7554/eLife.71982 (2021).
|
[66.] |
|
[67.] |
|
[68.] |
|
[69.] |
|
[70.] |
|
[71.] |
Balaskas, P. et al. MicroRNA Signatures in Cartilage Ageing and Osteoarthritis. Biomedicines 11 https://doi.org/10.3390/biomedicines11041189 (2023).
|
[72.] |
|
[73.] |
|
[74.] |
|
/
〈 |
|
〉 |